Skip to content
Search

Latest Stories

Health Improvement Scotland to regulate pharmacist-run independent clinics

Health Improvement Scotland to regulate pharmacist-run independent clinics

After 18 June 2025, it will be an offense for a pharmacist or pharmacy technician to operate a clinic without registration 

Pharmacists and pharmacy technicians in Scotland who wish to provide an independent clinic are now required to register with Health Improvement Scotland (HIS).


This follows a recent legislative change by the Scottish government, granting HIS authority to regulate independent clinics where services are provided by pharmacists and pharmacy technicians.

Implemented under sections 10G and 105(7) of the National Health Service (Scotland) Act 1978, the amendment also expands the definition of Independent Medical Agency (IMA) to cover services provided by dental practitioners, registered nurses, registered midwives, dental care professionals, pharmacists, and pharmacy technicians, including wholly online services based in Scotland.

Effective 19 June 2024, the legislative update also allows HIS to cancel the registration of independent healthcare services that fail to pay their continuation fees.

The change aims to “increase public safety and avoid situations where pharmacists and pharmacy technicians provide services from unregulated clinics … and where wholly online providers are able to provide services to patients in Scotland without being regulated.”

The government acknowledges that changes to IMAs are “particularly urgent” as online healthcare services that do not currently fall within regulation by HIS pose a “public health risk.”

However, the amendment provides a grace period of one year until 18 June 2025. During this time, clinics operated by unregistered pharmacists or pharmacy technicians will not face penalties, allowing them to apply for HIS registration.

Notably, the legislation excludes services provided in registered pharmacies and those under NHS contract.

The amendment follows a public consultation held from 1 February 2023 to 26 April 2023, during which the majority of respondents supported the proposed regulatory changes.

More For You

Walgreens Boots Alliance acquired by Sycamore in deal

Walgreens Boots Alliancehas entered into “a definitive agreement” to be acquired by Sycamore Partners

Gettyimages

Walgreens Boots Alliance acquired by Sycamore in £18.3 billion deal

Walgreens Boots Alliance(WBA) has entered into “a definitive agreement” to be acquired by Sycamore Partners, a private equity firm specializing in retail, consumer and distribution-related investments.

“The total value of the transaction represents up to $23.7 billion (£18.3 billion),” the company announced late last night (6).

Keep ReadingShow less
Professor Sir Stephen Powis at a press briefing

Professor Sir Stephen Powis, was appointed national medical director of NHS England in 2018

NHS

NHS England’s top doctor to step down following Amanda Pritchard’s resignation

Just a week after NHS England chief executive Amanda Pritchard announced her resignation, the organisation’s national medical director, Professor Sir Stephen Powis, has confirmed he will step down this summer after more than seven years in the role.

In a statement released on Thursday, Professor Powis revealed that he had informed Pritchard of his intention to leave in a letter back in January.

Keep ReadingShow less
PDA calls on GP practices to use funding boost to improve job security for pharmacists

Now, it is time to focus on the community pharmacy contract

gettyimages

PDA urges GP practices to ensure funding boost supports employed pharmacists

The Pharmacists' Defence Association (PDA) has called on GP practicesto ensure that all healthcare professionals they employ, including pharmacists, benefit from the 7.2% funding boost they received under a newly agreed contract.

GP employers are encouraged to improve “job security, pay and conditions” for employees with this increased funding.

Keep ReadingShow less
Fourth Shift: Investment in Innovative Medicines Crucial for NHS 10-Year Plan Success

Medicines should be viewed as an investment rather than a cost

gettyimages

ABPI wants to see a ‘fourth shift’ in NHS 10-Year Health Plan


The Association of the British Pharmaceutical Industry (ABPI) has called on the government to increase investment in innovative medicines and vaccines, describing it as a crucial “fourth shift” necessary to ensure the NHS is fit for the future.

Keep ReadingShow less
Lawrence Tallon named new MHRA chief executive

Lawrence Tallon

Photo credit: Sciana Network

Lawrence Tallon named new MHRA chief executive

Lawrence Tallon has been appointed as the new chief executive officer of the Medicines and Healthcare products Regulatory Agency (MHRA), effective 1 April 2025.

He will succeed Dame June Raine DBE, who is retiring after leading the agency since 2019.

Keep ReadingShow less